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time, a threshold level is presented for new bone formation 
after applying shock waves to intact bone in vivo. The find-
ings of this study are of considerable significance for pre-
venting unwanted side effects in new approaches in the clin-
ical application of shock waves.  
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 For almost 15 years, extracorporeal shock wave ther-
apy has been used in treatment for disorders of the mus-
culo-skeletal system. It has been used, with varying suc-
cess rates, for conditions such as tendinopathies, delayed 
bone healing, pseudarthrosis and aseptic femoral head 
necrosis  [1–3] . When shock waves were found to be effec-
tive for the treatment of nonunions in 1991  [4] , numerous 
groups investigated the effects of shock waves in animal 
models  [5–14] and clinical-experimental applications 
 [15–18] . Unfortunately, the application of extracorporeal 
shock wave therapy was not very standardized in terms 
of the strength and number of the impulses used, making 
comparisons between studies difficult. Today, the best 
way to characterize shock waves is the use of the energy 
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 Abstract 
 Background: Whereas various molecular working mecha-
nisms of shock waves have been demonstrated, no study has 
assessed in detail the influence of varying energy flux densi-
ties (EFD) on new bone formation in vivo.  Methods: Thirty 
Chinchilla bastard rabbits were randomly assigned to 5 
groups (EFD 0.0, 0.35, 0.5, 0.9 and 1.2 mJ/mm 2 ) and treated 
with extracorporeal shock waves at the distal femoral region 
(1,500 pulses; 1 Hz frequency). To investigate new bone for-
mation, animals were injected with oxytetracycline at days 
5–9 after shock wave application and sacrificed on day 10. 
Histological sections of all animals were examined using 
broad-band epifluorescent illumination, contact microradi-
ography and Giemsa-Eosin staining.  Results: Application of 
shock waves induced new bone formation beginning with 
0.5 mJ/mm 2 EFD and increasing with 0.9 mJ/mm 2 and 1.2 
mJ/mm 2 . The latter EFD resulted in new bone formation also 
on the dorsal cortical bone; cortical fractures and periosteal 
detachment also occurred.  Conclusion: Here, for the first 
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flux density (EFD; expressed in mJ/mm 2 ), which can be 
measured with laser hydrophones and accurately quanti-
fies the applied shock wave energy, independent of the 
shock wave generator type or voltage setting used  [19] .
 In recent years, the changes in molecular mechanisms 
induced by shock waves in tendon and bone have been 
partly investigated using animal and cell-culture models. 
Shock waves induce increased vascularization at the ten-
don-bone interface  [20] , increased collagen production 
and collagen cross-linking  [21] , and thereby promote heal-
ing of tendons. Shock waves also lead to increased biome-
chanical stability of tendons reattached to bone  [22] . At 
the same time, high-energy shock waves have been shown 
to cause tendon damage in a dose-dependent manner  [23–
25] . In cell-culture experiments, cells were also damaged 
by high-energy shock waves  [26] . At the cellular level in 
bone tissue, shock waves interact with numerous trans-
mitter systems, leading to new bone formation in physio-
logical as well as acutely fractured and pseudarthrotic 
bone  [9, 27–35] . Involvement of growth factors like tumor 
growth factor (TGF-  1), various bone morphogenetic 
proteins (BMP) and vascular endothelial growth factor 
(VEGF-a), or secretion of neurotransmitter substance P 
has been shown. Together, the activation of underlying 
molecular signal cascades mediated by kinases like extra-
cellular signal-regulated kinase (ERK), the G-protein RAS 
and p38 kinase have been elucidated  [9, 27–35] .
 For the clinical application of shock waves, the mech-
anisms of action are very important, but the dose of the 
shock wave energy is also an important factor. It has been 
speculated by many authors that the effect of shock waves 
on bone (under physiologic as well as pathologic condi-
tions) is also energy-dose dependent, but this has not 
been demonstrated yet. Therefore, the aim of this study 
was to investigate whether a dose-dependent effect of 
shock wave application on normal bone exists and to 
characterize the histological features of the newly formed 
bone. The results may serve as a guideline for further ap-
plication of shock waves in clinical studies and could help 
to define a minimal energy dose that still leads to new 
bone formation in the rabbit model. In recent publica-
tions, remote effects of shock wave application on bone 
have been described. These effects include humeral head 
osteonecrosis, pulmonary embolism and tendon damage, 
particularly when high-energy shock waves with EFD 
over 0.9 mJ/mm 2 were used  [11, 23, 36, 37] . Therefore, for 
the clinical application of shock waves, it is also very im-
portant to define a dose–effect relationship, in order to 
minimize side effects on the musculoskeletal system and 
improve the efficacy of this technique. 
 Materials and Methods 
 Animals 
 Thirty female Chinchilla bastard rabbits were investigated 
[exbreeders, 1 year old, body weight (BW) 4,200–4,900 g, closed 
femoral growth plates]. Animals were purchased from a provider 
of animal research models (Charles River, Kisslegg, Germany). 
During the experimental period, animals were maintained on a 
12: 12 h light:dark cycle with lights on at 6:00 a.m. and access to 
standard food pellets and water ad libitum. Animals were ran-
domly assigned to 1 of 5 groups (n = 6 rabbits per group), differing 
with respect to the EFD of the applied extracorporeal shock waves 
(0.0, 0.35, 0.5, 0.9 and 1.2 mJ/mm 2 ;  table 1 ). For each animal either 
the left or the right hindlimb was randomly selected for extracor-
poreal shock wave application, with the other hindlimb serving 
as control. All research and animal care procedures were ap-
proved by the local district government animal utilization study 
committee.
 Anesthesia 
 Extracorporeal shock wave application was carried out under 
deep intravenous anesthesia. Anesthesia was initialized by intra-
venous injection of a combination of xylazine hydrochlorid (1.5 
mg/kg BW) and ketamine (6 mg/kg BW) and was maintained by 
intravenously applying 2.4 mg/kg BW per hour xylazine hydro-
chlorid and 10 mg/kg BW per hour ketamine by means of a per-
fusion pump. During anesthesia, animals were supplied with ox-
ygen by an oxygen mask. Administration of intravenous drugs 
was terminated immediately after shock wave application.
 Extracorporeal Shock Wave Application 
 After shaving both hindlimbs, animals were positioned for ex-
tracorporeal shock wave application as previously described in 
detail  [10] . Extracorporeal shock waves were applied to all ani-
mals as 1,500 shock wave pulses at 1 Hz frequency during 25 min. 
Shock waves with EFD of either 0.0 mJ/mm 2 (sham treatment),
0.5 mJ/mm 2 , 0.9 mJ/mm 2 or 1.2 mJ/mm 2 (n = 6 animals per group) 
were applied to the distal femoral region of the selected hindlimb 
using an electrohydraulic shock wave source (XL1; Dornier 
MedTech, Wessling, Germany). The shock wave device was cou-
pled to the selected distal femoral region by means of a water bath. 
Two laser pointers adjusted in 2 planes controlled focusing of the 
shock waves to the distal femur, the waves were directed from the 
Table 1. Animal groups and physical shock wave parameters used 
for treatment
Group Shock wave 
device
kV EFD
mJ/mm2
Impulses
n
Frequency
Hz
A EPOS * 0.35 1,500 1
B XL1 15 0.5 1,500 1
C XL1 20 0.9 1,500 1
D XL1 25 1.2 1,500 1
E XL1 0 0 1,500 1
* The EPOS shock wave source is not adjusted using kV.
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anterior femur posteriorly. In the case of sham treatment, the pro-
cedure was identical to those carried out for the treatment with 
1.2 mJ/mm 2 . However, the treated hindlimb was protected by a 
Styrofoam box that was impermeable to shock waves. Since an 
EFD of 0.35 mJ/mm 2 could not be generated with the electrohy-
draulic device, shock wave application at this EFD (n = 6 animals) 
was carried out with an electromagnetic shock-wave source 
(EPOS Ultra; Dornier MedTech, Germany). The shock wave 
source was coupled to the distal femoral region at the same region 
as with the XL-1 device ( fig. 1 a) by means of clinically used ultra-
sound jelly between application device (cylinder) and skin. Shock 
wave focusing to the distal femur was controlled by an outline 
ultrasound-system (7.5 MHz linear scan) integrated into the 
shock wave device. 
 Prior to each shock wave application, the EFD of the focus 
zone was measured with a laser hydrophone (Imotec, Mühlanger, 
Germany)  [11, 38, 39] . By this approach, it is possible to compare 
the effects of different shock wave generators (electromagnetic or 
electrohydraulic). The measured size of the –6 dB focus zone was 
5 mm ( fig. 1 a). This focus zone includes all parts of the shock wave 
field, where the positive pressure is  1 50% of the peak positive 
pressure. 
 In vivo Bone Labeling 
 All animals received subcutaneous injections of 25 mg/kg BW 
oxytetracycline (5%; Atarost, Twistringen, Germany) at varying 
sites of the back at each of days 5–9 after extracorporeal shock 
wave application, modified from the protocol established by De-
lius et al.  [5] . 
 Analysis of Bones 
 Animals were sacrificed by a pentobarbital overdose 10 days 
after extracorporeal shock wave application. Both femurs were 
exarticulated in the hip and knee joint, fixed in methanol (100%) 
for 14 days, dehydrated and block-embedded in methylmethacry-
late. Since total femur length varied only between 9.9 cm and 10.2 
cm, for the further analysis each specimen was shortened to 5 cm 
(with a diamond band saw; Exakt, Norderstedt, Germany) for in-
vestigation of the focus zone and then cut to 100   m-thick sagit-
tal sections from anterior to posterior using a saw microtome 
(Leica SP 1600; Leitz, Wetzlar, Germany). Intervals between sec-
tions were 800   m, and 5–7 sections were obtained from each 
femur. Bones were evaluated by means of broad-band epifluores-
cent illumination, contact microradiography and histological ex-
amination using Giemsa-Eosin staining.
 Epifluorescent illumination was carried out with a micro-
scope (Axiophot; Zeiss, Göttingen, Germany) using a fluorescent 
filter system (filter no. 25; Zeiss, Germany), fluorescent light 
source (HBO-100, Zeiss) and video camera (MC 3255P, Sony, Ja-
pan). Quantitative analysis was performed online using an image 
analysis system (Kontron KS 400; Zeiss). For all femurs, the fol-
lowing parameters were investigated at both the periosteal ventral 
and dorsal sites as well as at the endosteal ventral and dorsal sites: 
(1) maximum thickness of new bone formation measured perpen-
dicular from the bone surface and (2) percentage of bone length 
showing new bone, classified into class 1 (0–33%), class 2 (34–
66%) and class 3 (67–100%) ( fig. 1 ). At the beginning of each in-
vestigation, the image analysis system was adjusted with a cali-
brated scale (Zeiss). The precision of the measurements was
 8 10   m. 
 Contact microradiography was performed on high-resolution 
photo plates (IMTEC, Sunnyvale, Calif., USA) using a Faxitron 
Microfocus System (Hewlett-Packard; Palo Alto, Calif., USA) 
with a period of exposure of 60 min at 17 kV and 2 mA. Further-
more, sections were independently and blindly evaluated by 2 
pathologists experienced with the musculoskeletal system using 
a Leitz Dialux 20 EB light microscope (Leitz). For all femora, the 
following parameters were investigated at the periosteal ventral 
site and the trabecular bone of the metaphysis and diaphysis: 
presence of periosteal new bone apposition, periosteal detach-
ment, cortical fractures, and trabecular bone with callus. The 
data were scored into 3 classes. Class 1 (no sign of the investi-
gated variables, score 1), class 2 (moderate signs of the investi-
gated variables, score 2) and class 3 (distinct signs of the investi-
 Fig. 1.  a Measurements of the rabbit femur. After sagital sections 
were obtained, new bone formation was measured on the perios-
teal-ventral (1), endosteal-ventral (2), endosteal-dorsal (3) and 
periosteal-dorsal (4) side. Further, the percentage of the length of 
new bone formation was divided into 3 classes (see text for de-
tails). L = 5 cm; F = –6 dB focus zone of shock waves.  b Micro-
radiography of a treated femur with EFD 1.2 mJ/mm 2 . Single
arrow = periosteal-ventral new bone formation; double arrow = 
periosteal-dorsal new bone formation.  c Detailed view of ventral-
periosteal new bone formation after ESWA with EFD 1.2 mJ/mm 2 
(same specimen as shown in  b ). Scale bar = 2,000   m.  d Histo-
logical view of ventral cortical bone with new appositional bone 
formation and 2 cortical fractures filled with fibrous tissues (ar-
rows). Giemsa-Eosin staining. Scale bar = 1,000   m.  e High-pow-
er image showing the border (arrow) between cortical bone and 
newly formed bone. Giemsa-Eosin staining. Asterisk = osteo-
clasts; scale bar = 250   m.  f High-power image showing tetracy-
cline fluorescence labeling of the same region as shown in  c . Cor-
tical bone (asterisk) is unstained. Scale bar = 500   m.  g Microra-
diography shows periosteal-dorsal new bone formation after 
ESWA with 1.2 mJ/mm 2 . Arrow = periosteal-dorsal new bone for-
mation; asterisk = endosteal side; scale bar = 2,000   m.  h High-
power tetracycline labeling of callus formation (arrow) in trabec-
ular fractures in the femur condyle after ESWA with EFD 1.2 mJ/
mm 2 . Asterisk = unstained trabecular bone; scale bar = 250   m. 
 i High-power view of trabecular fracture (arrow) with newly 
formed surrounding callus (asterisk). Giemsa-Eosin staining. 
Scale bar = 250   m.  k Microradiography of periosteal-ventral new 
bone formation (arrow) after ESWA with 0.9 mJ/mm 2 . Note that 
the amount of new bone formation is substantially lower than in 
 c . Scale bar = 2,000   m.  l Dorsal cortical bone showing no peri-
osteal-dorsal new bone formation after ESWA with EFD 0.9 mJ/
mm 2 . Asterisk = endosteal side; scale bar = 2,000   m.  m Minimal 
periosteal-ventral new bone formation after ESWA with EFD 0.5 
mJ/mm 2 is seen in this microradiographic image. Inset shows 
same region as shown in  i . There is a small irregular bone for-
mation on the periosteal surface (arrow). Scale bar = 2,000   m. 
 n Untreated side of the animal as seen in  c . No appositional new 
bone formation is seen with regular periost. Giemsa-Eosin stain-
ing. Scale bar = 250   m.  o High-power fluorescence-labeling im-
age of sham-treated group showing no new bone formation. As-
terisk = cortical bone; scale bar = 500   m.  
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gated variables, score 3). All histomorphometric gradings were 
assessed independently by 2 pathologists. Any differences be-
tween the classification of the 2 pathologists were resolved in 
conference.
 After grinding and polishing (Schleifsystem 400 CS, Exakt), 
selected specimens were stained using Giemsa-Eosin and evalu-
ated for signs of newly formed bone and callus formation.
 Statistical Analysis 
 For each group of animals, the mean and standard error of 
the mean (SEM) were calculated for all investigated variables. 
Comparisons between groups (i.e., between different EFDs) 
were performed using nonparametric Spearman’s rank correla-
tion, separately for the treated and the untreated femora. For the 
investigation of the maximum thickness of new bone formation, 
the Wilcoxon matched pairs test was applied for comparisons 
within groups. In cases of extension of new bone formation, 
comparisons within groups (i.e., between treated and untreated 
femora of the same animals) were performed using 2 or Fisher’s 
test, respectively. The latter test was used if one class (i.e., 1, 2 or 
3) was not recorded for both the treated and the untreated fem-
ora. Differences were considered as statistically significant at p 
 ! 0.05. All calculations were carried out using GraphPad Prism 
version 4.00 for Macintosh (GraphPad Software; San Diego, Ca-
lif., USA).
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 Fig. 2. Maximum new bone formation dependent on the applied EFD (0.0, 0.35, 0.5, 0.9 and 1.2 mJ/mm 2 ) for 
the periosteal ventral, periosteal dorsal, endosteal ventral and endosteal dorsal side. Data are mean  8 SEM. 
Filled circles = treated femur; open circles = untreated femur. Statistical significance between treated and un-
treated femur is marked with p  ! 0.05. 
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 Results 
 Extracorporeal shock-wave application to the distal 
femoral region of the rabbit resulted in macroscopically 
detectable hematomas in the focus zone of every animal 
in the group treated with EFD 1.2 mJ/mm 2 and slight he-
matomas were detected in the animals treated with 0.9 
mJ/mm 2 . No hematomas were found in any other animal. 
Microscopically, clearly detectable, dose dependent signs 
of new bone formation, mostly on the periosteal-ventral 
side were found ( fig. 1 ). 
 With respect to the investigations with epifluorescent 
illumination, the most distinct effects of shock wave ap-
plication were found at the periosteal-ventral site of the 
treated femur. These effects comprised statistically sig-
nificant positive correlations between the applied EFD, 
the maximum thickness of new bone formation and the 
percentage of bone length showing new bone ( fig. 2 and 
 3 ). Furthermore, there were statistically significant dif-
ferences between the treated and the untreated femurs of 
the same animals at the periosteal-ventral sites for the 
maximum thickness of new bone formation at EFDs of 
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 Fig. 3. Maximum length of new bone formation dependent on the applied EFD (0.0, 0.35, 0.5, 0.9 and 1.2 mJ/
mm 2 ) for the periosteal ventral, periosteal dorseal, endostal ventral and endosteal dorsal side, classified in three 
groups (class 1 = 0–33%; class 2 = 34–66%; class 3 = 67–100%). Data are mean  8 SEM. Filled circles = treated 
femur; open circles = untreated femur. Statistical significance between treated and untreated femur is marked 
with p  ! 0.05. 
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0.5 mJ/mm 2 (p = 0.031), 0.9 mJ/mm 2 (p = 0.031) and 1.2 
mJ/mm 2 (p = 0.031) and for the percentage of total bone 
length showing new bone at EFDs of 0.9 mJ/mm 2 (p = 
0.003) and 1.2 mJ/mm 2 (p = 0.014). Moderate effects of 
shock wave application were found at the periosteal dor-
sal site of the treated femur. However, statistical signifi-
cance was only obtained for differences between the 
treated and the untreated femur of the same animals at 
EFD of 1.2 mJ/mm 2 for the maximum thickness of new 
bone formation periosteal-dorsal (p = 0.031) and the per-
centage of bone length showing new bone periosteal-dor-
sal (p = 0.013). At the endosteal sites of the femur, no sta-
tistically significant effects of the applied shock waves 
were found. All data of the investigations with epifluores-
cent illumination are displayed in  figures 2 and  3 .
 The investigations with contact microradiography re-
vealed statistically significant positive correlations in the 
treated femura between the applied energy flux density 
and periosteal new bone apposition [Spearman r (r) = 
1.000, p = 0.017], periosteal detachment (r = 0.975, p = 
0.017), and cortical fractures (r = 1.000, p = 0.017) at the 
periosteal ventral site and the trabecular bone of the me-
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 Fig. 4. Results of the contact microradiograpic analysis. New bone apposition (periosteal ventral), periosteal 
detachment (ventral), cortical fractures (ventral) and trabeculae with callus in the femur condyle are recorded. 
Values shown are mean values per group obtained from the individual classification scores (see text for details). 
Data are mean  8 SEM. Filled circles = treated femur; open circles = untreated femur. For statistical details see 
text. 
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taphysis and diaphysis. No statistically significant corre-
lation was found for trabecular bone with callus (r = 
0.975, p = 0.167). By contrast, no correlations were found 
between the applied EFD and the investigated variables 
at the untreated femur. Furthermore, statistically signifi-
cant differences between the treated and the untreated 
femur of the same animals were found for periosteal new 
bone apposition at EFDs of 0.5 mJ/mm 2 (p = 0.003), 0.9 
mJ/mm 2 (p = 0.007) and 1.2 mJ/mm 2 (p = 0.002), perios-
teal detachment at EFDs of 0.9 mJ/mm 2 (p = 0.036) and 
1.2 mJ/mm 2 (p = 0.003) and trabecular bone with callus 
at EFDs of 0.5 mJ/mm 2 (p = 0.014), 0.9 mJ/mm 2 (p = 0.003) 
and 1.2 mJ/mm 2 (p = 0.002). For cortical fractures, statis-
tically significant differences between the treated and the 
untreated femur of the same animals were restricted to 
EFDs of 0.9 mJ/mm 2 (p = 0.027) and 1.2 mJ/mm 2 (p = 
0.003), but were not observed at 0.5 mJ/mm 2 (p = 0.264). 
All data of the investigations with contact microradiog-
raphy are displayed in  figure 4 . 
 Histologically, these results were confirmed. The new-
ly formed bone was easily discerned by its cell-rich, eo-
sinophilic matrix which showed the typical characteris-
tics of woven bone ( fig. 1 e). In this area, signs of apposi-
tional bone formation were detectable with an increase in 
resorption lacunes with osteoclasts and a prominent lay-
er of osteoblasts. Cortical fractures were filled with fi-
brous tissue ( fig. 1 d) and trabecular fractures showed 
chondrogenic and osteogenic callus tissue ( fig. 1 i). In 
contrast, the untreated femur showed no new bone for-
mation ( fig. 1 n).
 Discussion 
 The investigations were performed on an established 
animal model of extracorporeal shock wave application to 
the musculoskeletal system  [5, 10] . In line with previous 
reports of extracorporeal shock wave therapy in animal 
models  [5, 11, 13, 14, 40] , the present study shows shock 
wave mediated new bone formation. In recent publica-
tions a dose-dependent effect has been assumed; however, 
this was based on only 1 low-dose group receiving 2,000 
shock wave impulses with EFD 0.18 mJ/mm 2 and 1 high-
dose group receiving 4,000 shock wave impulses with 
EFD of 0.47 mJ/mm 2 in a fracture model  [33] . Here, a 
threshold value for new bone formation is presented, as-
sessing 5 different EFD levels. Extracorporeal shock wave 
application resulted in a dose-dependent increase of peri-
osteal new bone formation, requiring a minimum dose of 
0.5 mJ/mm 2 to create any effect at all in this animal mod-
el. The amount of new bone formation then increased 
with increasing EFD (0.9 and 1.2 mJ/mm 2 , p  ! 0.05). 
 When using a high EFD of 1.2 mJ/mm 2 new bone for-
mation was also seen on the dorsal periosteal side of the 
femur. A remote action of shock waves on new bone for-
mation has already been shown for the ventral cortical 
bone, but not for the dorsal cortical bone  [11] . Trabecular 
fracturing in the femur condyle also occurred, even with 
lower EFD. This should be considered by the clinician 
when calculating possible side effects, especially when 
using shock waves with a relatively high EFD ( 6 1.2 mJ/
mm 2 )  [7] . Other serious complications, like pulmonary 
embolism, have been described in the same animal mod-
el also using an EFD of 1.2 mJ/mm 2  [36] . Recently, after 
high-energy shock wave therapy (EFD 0.78 mJ/mm 2 ; 
3,000 impulses) for rotator cuff tendinopathy in humans, 
humeral head osteonecrosis was reported. There was no 
hint of any etiology other than the shock waves  [37] . 
These unwanted side effects could possibly be minimized 
when using shock waves with an EFD just high enough 
to induce new bone formation (in cases of bone stimula-
tion during fracture repair or treatment of pseudarthro-
ses) but not so high as to induce major side effects. Fur-
thermore, when treating soft tissue disorders like tendi-
nopathies with shock waves, new bone formation has to 
be strictly avoided in order to prevent nerve entrapment 
syndromes, such as at the elbow or impingement syn-
dromes at the shoulder.
 Earlier explanations for shock wave-induced bone for-
mation were based on the concept of mechanically in-
duced microfractures and periosteal detachment  [4, 5, 7] . 
We can here confirm that shock waves lead to cortical 
fractures, periosteal detachment, trabecular fractures 
and callus formation. According to Ikeda et al.  [7] , micro-
fractures are necessary for the generation of new bone. In 
our study, we observed periosteal bone apposition with 
only minimal production of microfractures (EFD 0.5 mJ/
mm 2 ), indicating that this might not be the prevalent 
mechanism for new bone formation. Similar concerns 
were previously raised by our group  [40] . Furthermore, 
the release of growth factors (TGF-  1, VEGF-a and BMP) 
and other mediators (substance P) that affect bone forma-
tion has been shown recently in the rabbit and rat models 
 [9, 10, 31, 35] , which suggests other molecular mecha-
nisms may have a role in the induction of new bone for-
mation.
 Despite the relatively widespread clinical use of EFD, 
the physical parameters for its clinical application (the 
dose and number of shock wave impulses), for the treat-
ment of individual diseases still have to be standardized. 
 Tischer /Milz /Weiler /Pautke /Hausdorf /
Schmitz /Maier 
Eur Surg Res 2008;41:44–5352
Since now a dose-dependent relationship between shock 
waves and biological action has been clearly proven, more 
clinical studies defining suitable EFD and number of 
shock wave impulses for single diseases have to be per-
formed, especially since this information cannot be di-
rectly transferred to the pathological situation of frac-
tured bone or nonunion in human bones. For example, 
in the treatment of tibial nonunion, Schaden et al. [17] 
used shock waves with an EFD of 0.4 mJ/mm 2 and 12,000 
impulses and achieved union in 26 out of 34 patients. 
Wang et al.  [18] used similar physical parameters, but 
with EFD a little higher and fewer impulses (EFD 0.62 
mJ/mm 2 ; 6,000 impulses). Clinical results were similar. 
Finally, Rompe et al.  [16]  achieved healing rates of about 
70% of tibial nonunions when using shock waves with 
EFD 0.6 mJ/mm 2 and 3,000 impulses. Other groups using 
different physical parameters were not as successful  [15] , 
highlighting the importance of a clearly defined energy 
dose for shock wave applications. 
 We conclude that the results presented here have sig-
nificant impact on further clinical application of shock 
waves on bone tissue. In the present study, it is clearly 
demonstrated that the amount of new bone formation is 
directly dependent on the applied EFD. If the applied 
EFD is too low, no significant new bone formation will 
occur. If it is too high, unwanted side effects, like the for-
mation of bone spurs in the shoulder or nerve entrapment 
syndromes in the elbow or feet by bony overgrowth, may 
result when treating tendionopathies. 
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